{
  "paper_metadata": {
    "pmid": "35743882",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4314A>G",
      "protein_notation": "p.Lys1435Arg",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 4,
        "demographics": "Canine, various breeds",
        "phenotype": "Intraductal papillary carcinoma, solid carcinoma, complex carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 22,
        "affected_count": 4,
        "unaffected_count": 18,
        "uncertain_count": 0,
        "penetrance_percentage": 18.18,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Intraductal papillary carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Solid carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Complex carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Intraductal papillary carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        }
      ],
      "functional_data": {
        "summary": "The c.4314A>G variant is located in the BRC3 repeat domain, which plays a fundamental role in the interaction with the protein RAD51.",
        "assays": []
      },
      "segregation_data": "The variant was found in affected dogs but not in healthy controls.",
      "population_frequency": null,
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was confirmed by Sanger sequencing.",
      "key_quotes": [
        "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4283A>C",
      "protein_notation": "p.Thr1425Pro",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 4,
        "demographics": "Canine, various breeds",
        "phenotype": "Intraductal papillary carcinoma, solid carcinoma, complex carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 22,
        "affected_count": 4,
        "unaffected_count": 18,
        "uncertain_count": 0,
        "penetrance_percentage": 18.18,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Intraductal papillary carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Solid carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Complex carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Intraductal papillary carcinoma",
          "evidence_sentence": "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
        }
      ],
      "functional_data": {
        "summary": "The c.4283A>C variant is located in the BRC3 repeat domain, which plays a fundamental role in the interaction with the protein RAD51.",
        "assays": []
      },
      "segregation_data": "The variant was found in affected dogs but not in healthy controls.",
      "population_frequency": null,
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was confirmed by Sanger sequencing.",
      "key_quotes": [
        "Four out of 22 different dogs (ID: 2, 4, 14, 15) showed c.4314A>G\u2014p.(Lys1435Arg) together with c.4283A>C\u2014p.(Thr1425Pro), both in exon 11 of BRCA2 and previously described in the literature as implicated in carcinogenesis of dogs."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.10204_10206insAAA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 18,
        "demographics": "Canine, various breeds",
        "phenotype": "Mammary tumors"
      },
      "penetrance_data": {
        "total_carriers_observed": 22,
        "affected_count": null,
        "unaffected_count": 4,
        "uncertain_count": 0,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The c.10204_10206insAAA variation is positioned in the nuclear localization signal 2 (NLS2), which plays a key role in the mislocation of BRCA2 in humans.",
        "assays": []
      },
      "segregation_data": "The variant was found in affected dogs but not in healthy controls.",
      "population_frequency": null,
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Recent studies suggest that c.10204_10206insAAA may be associated with significantly higher mammary tumor morbidity rates in dogs.",
      "key_quotes": [
        "We found this insertion in 18 out of 22 dogs (81%) in exon 27 of BRCA2."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 3",
      "table_caption": "Summary of genetic variants identified in BRCA2",
      "variants_extracted": 23
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 23,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were extracted successfully."
  }
}